Bill McCue

Focus on Fingernails

From the Editor The PRP Survival Guide is a repository of experiences and insights shared by PRP patients and their caregivers. Collectively, the PRP community possesses a wealth of practical knowledge about pityriasis rubra pilaris. We need to harvest that knowledge for those in need of enlightenment. Share what you have learned about the impact […]

Focus on Fingernails Read More »

UCLA PRP Survey

There has never been a WORLDWIDE SCIENTIFIC SURVEY of 1,000 PRP patients! … until now. On July 29, 2018, over 1,100 PRP patients (or their caregivers) were invited to participate in the UCLA PRP Survey. While 418 (41%) opened the email, only 128 clicked the link to the UCLA PRP Survey page. Said another way:

UCLA PRP Survey Read More »

ARCHIVE PRP Advocacy

As an ultra-rare skin disorder, PRP must find allies to open doors. How can the PRP community most effectively impact improvements in the diagnosis, treatment and research for PRP? Some basic questions… What is a patient advocate? What is a PRP advocate? What are the advocacy Issues? ❏½ PRP Advocacy Agenda – June 2017 With

ARCHIVE PRP Advocacy Read More »

PRP Research

The PRP community has long lamented the lack of research. Since October 2012, however, researchers at Thomas Jefferson University have been conducting ongoing genetic research. In 2014 their research efforts expanded to include clinical analysis. For all intents and purposes, TJU was the only game in town. ❏½ What is the status of PRP Research?

PRP Research Read More »

How to Use the PRP Survival Guide

From the Editor I was diagnosed with pityriasis rubra pilaris (PRP) on November 28, 2012 – nearly three months after a red spot appeared on my forehead. Someone from my dermatologist’s office called me to confirm the diagnosis and to schedule an appointment for the following day. All she shared with me was the proper

How to Use the PRP Survival Guide Read More »

The Dowling Oration

The Dowling Oration was delivered by Dr. Andrew Griffiths in Liverpool, England in March 2003 as he reflected on 35 years as a dermatologist. It is frequently used as a reference in PRP-related research. To explain his methodology for calculating the prevalence rate of pityriasis rubra pilaris, Griffiths writes: “Most dermatologists never have a new

The Dowling Oration Read More »